Here are relevant reports on : drug-discovery-and-development-market

• Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), by Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & Marketing, Drug Safety), End User (Pharma, Medical Device) & Region - Global Forecast to 2030

  Global life science analytics market valued at $35.69B in 2024, reached $40.03B in 2025, and is projected to grow at a robust 11.4% CAGR, hitting $68.81B by 2030. Emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• Chemoinformatics Market by Application (Chemical Analysis (Chemical Databases, Chemo Metrics, Molecular Modelling), Drug Discovery (High Throughput Screening, Lead Identification and Optimization, QSAR/QSPR), Drug Validation) - Global Forecast to 2023

  Growth of the chemoinformatics market is primarily driven by innovations and advancements in the drug development process, advances in the computer technology, increased demand of personalized medicine. On the other hand, cost associated with the chemoinformatics software is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• Material Informatics Market by Material (Chemicals, Superalloys, Solid-state Electrolytes, Composites), Technique (Statistical Analysis, Genetic Algorithm), Application (Materials Discovery, Product Development) and Region - Global Forecast to 2030

  The global material informatics market is expected to grow from USD 170.4 million in 2025 to USD 410.4 million in 2030, at a compound annual growth rate (CAGR) of 19.2% during the forecast period. The key players Schrödinger, Inc. (US), Dassault Systèmes (France), Exabyte Inc. (US), Citrine Informatics (US), Phaseshift Technologies (Canada), AI Materia (Canada), Hitachi High-Tech Corporation (Japan), Kebotix, Inc. (US), Materials Design, Inc. (US), and MaterialsZone (Israel).

  • Published: February 2025
  • Price: $ 4950
  • TOC Available:

• Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023

  The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).

  • Published: September 2018
  • Price: $ 4950
  • TOC Available:

• Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) & Region - Global Forecasts to 2023

  The global apoptosis assays market is projected to reach USD 5.9 billion by 2023, at a CAGR of 10.5%. The prominent players in the apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).

  • Published: November 2018
  • Price: $ 4950
  • TOC Available:

• Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030

  The global real world evidence solutions market, valued at US$4.74 billion in 2024, stood at US$5.42 billion in 2025 and is projected to advance at a resilient CAGR of 14.8% from 2025 to 2030, culminating in a forecasted valuation of US$10.8 billion by the end of the period.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023

  The lung in vitro models market is projected to reach USD 427.4 Million by 2023, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in Cell Culture technologies, and the development of new 3D in vitro models. The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

  • Published: April 2018
  • Price: $ 11000
  • TOC Available:

• Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule), Biologics (API, FDF), Packaging & Labelling, Fill-finish), Molecule (Small, Large (ADC, CGT)) - Global Forecast to 2030

  The global pharmaceutical contract manufacturing market, valued at US$193.52 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for outsourcing services for GLP-1 manufacturing, the growing ADC outsourcing for commercialized products, and the development and patent expiry of blockbuster biologics, which are paving the way for key biosimilars.

  • Published: August 2025
  • Price: $ 4950
  • TOC Available:

• APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027

  The global APAC spatial genomics & transcriptomics market, stood at US$64 million in 2022 and is projected to advance at a resilient CAGR of 18.9% from 2023 to 2027, culminating in a forecasted valuation of US$152 million by the end of the period.

  • Published: January 2023
  • Price: $ 4950
  • TOC Available:

• Liquid Handling System Market by Type (Automated, Electronic, Manual), Product (Pipettes, Consumables, Accessories, Software), Application (Drug Discovery, Genomics, Diagnostics, Proteomics, Food, Forensic, Environmental), End User, Region - Global Forecasts to 2030

  The global liquid handling systems market, valued at US$4.7B in 2024, is forecasted to grow at a 8.0% CAGR, reaching US$ 5.1B by 2025 and US$7.4B by 2030. The increasing trend of outsourcing pharmaceutical research enables businesses to cut costs and obtain specialty expertise. Rising investments in life sciences research and development are helping fuel innovation across the drug discovery and development process.

  • Published: May 2025
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS
• NEXT
• LAST

Records 11 to 20 of 50